MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Key neural tracts involved in tau depositions and neurodegeneration as revealed by multimodal MRI and PET assays in progressive supranuclear palsy

    R. Goto, H. Endo, K. Tagai, Y. Kataoka, K. Hirata, K. Matsuoka, N. Kokubo, M. Oya, H. Matsumoto, S. Kurose, M. Ichihashi, C. Seki, S. Kitamura, S. Moriguchi, K. Takahata, T. Tokuda, Y. Takado, H. Shinotoh, H. Shimada, K. Kawamura, M-R. Zhang, T. Toda, M. Higuchi (Chiba-shi, Japan)

    Objective: Our study aimed to elucidate the impact of tau depositions on brain microstructure and macrostructure in progressive supranuclear palsy (PSP). Background: The link between…
  • 2024 International Congress

    Value of DaTSPECT in rare movement disorders: neurodegenerative diseases

    E. Ardila Jurado, L. Zünd-Hofer, F. Brugger, G. Kägi (St Gallen, Switzerland)

    Objective: To explore the expanding indications of dopamine transporter imaging (DaT Spect) beyond the established indications. Background: DaTSPECT is a well-established method to rule out…
  • 2024 International Congress

    Metabolic characteristics of brain network in patients with Parkinson’s disease after Deep brain stimulation

    WEI. Lin, LJJ. Jin, KLY. Yang, HYW. Wang (WUXI CITY, China)

    Objective: The purpose of this study is to observe the short-term brain metabolic network characteristics of Parkinson's disease patients after STN DBS treatment through PET-CT…
  • 2024 International Congress

    Neural Correlates of Dual Task Touchscreen Performance in Parkinson’s Disease

    J. de Vleeschhauwer, N. D'Cruz, I. Orlando, J. Tan, E. Nackaerts, W. Vandenberghe, S. Lewis, M. Shine, A. Nieuwboer (Leuven, Belgium)

    Objective: To compare task-related brain activity during a touchscreen task in Parkinson’s disease (PD) patients and healthy controls (HC) in single (ST) and dual task…
  • 2024 International Congress

    Classification of Parkinson’s disease using AI based on multi-modal brain MRI connectomics

    T. Teo, T. Welton (Singapore, Singapore)

    Objective: To develop a novel artificial intelligence (AI) model using connectivity matrices derived from multi-modal brain magnetic resonance imaging (MRI) to aid diagnosis and subtyping…
  • 2024 International Congress

    Evaluating the association between cognitive impairment and striatal VMAT2 binding using [18F]AV-133 PET in Parkinson’s disease

    K. Hwang, J. Langley (Long Beach, USA)

    Objective: To evaluate the association between cognitive deficits and striatal vesicular monoamine transporter type 2 (VMAT2) binding in participants with Parkinson’s disease (PD) using [18F]AV-133…
  • 2024 International Congress

    Serotonergic dysfunction and impulse control disorders in Parkinson’s disease: a double-tracer PET study

    S. Prange, E. Metereau, H. Klinger, M. Hudlestone, N. Costes, S. Lancelot, S. Thobois (Bron, France)

    Objective: To investigate the dysfunction of the serotonergic system related to impulse control disorders in patients with Parkinson’s disease. Background: Impulse control disorders (ICDs, including…
  • 2024 International Congress

    Sex Cerebral Vasoreactivity Differences in Parkinson’s Disease: Uncovering the Tip of the Iceberg

    M. Cansino Torres, D. Ortiz Zacarias, A. Rodríguez Martínez, J. Trejo Ayala, S. Castillo Torres, F. Góngora Rivera, B. Chávez Luévanos, I. Estrada Bellman (Monterrey, Mexico)

    Objective: To determine sex differences in cerebral vasoreactivity (cVR) in patients with Parkinson’s disease (PD) and its association with the clinical spectrum of the disease.…
  • 2024 International Congress

    Impact on quality of life and nonmotor symptoms of unilateral magnetic resonance-guided focused ultrasounds (FUS) thalamotomy in patients with essential tremor.

    D. Vilas, L. Ispierto, M. Tardáguila, J. Muñoz, A. González, M. Gea, JA. Pérez, R. García-Yuste, R. álvarez (Badalona, Spain)

    Objective: To describe the impact on quality of life (QoL) and nonmotor symptoms of unilateral magnetic resonance-guided focused ultrasounds (FUS) thalamotomy in patients with refractory…
  • 2024 International Congress

    A Double-blind, Randomized, Crossover Clinical Trial comparing VIM vs. PSA Deep Brain Stimulation for Disabling Essential Tremor

    L. Triguero-Cueva, CJ. Madrid Navarro, MJ. Perez Navarro, B. Iáñez Velasco, JP. Martínez Barbero, B. Marín-Romero, A. Mínguez-Castellanos, F. Escamilla-Sevilla, M. Jouma Katati (Granada, Spain)

    Objective: To compare the efficacy, safety, energy efficiency and quality of life (QoL) of bilateral PSA-DBS versus bilateral VIM-DBS in the treatment of essential tremor…
  • « Previous Page
  • 1
  • …
  • 145
  • 146
  • 147
  • 148
  • 149
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley